Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
| MER Indicator |
MER description |
Target Fiscal Year |
Target |
| HTS_SELF |
|
2019 |
13,503 |
| HTS_SELF |
15-19, Female, Unassisted |
2019 |
654 |
| HTS_SELF |
15-19, Male, Unassisted |
2019 |
600 |
| HTS_SELF |
20-24, Female, Unassisted |
2019 |
1,062 |
| HTS_SELF |
20-24, Male, Unassisted |
2019 |
1,200 |
| HTS_SELF |
25-29, Female, Unassisted |
2019 |
600 |
| HTS_SELF |
25-29, Male, Unassisted |
2019 |
1,692 |
| HTS_SELF |
30-34, Female, Unassisted |
2019 |
1,200 |
| HTS_SELF |
30-34, Male, Unassisted |
2019 |
871 |
| HTS_SELF |
35-39, Female, Unassisted |
2019 |
750 |
| HTS_SELF |
35-39, Male, Unassisted |
2019 |
1,500 |
| HTS_SELF |
40-49, Female, Unassisted |
2019 |
2,400 |
| HTS_SELF |
40-49, Male, Unassisted |
2019 |
523 |
| HTS_SELF |
50+, Female, Unassisted |
2019 |
600 |
| HTS_SELF |
50+, Male, Unassisted |
2019 |
1,350 |
| HTS_SELF |
Unassisted |
2019 |
13,503 |
| HTS_TST |
25-29, Female, Negative |
2019 |
13 |
| HTS_TST |
25-29, Female, Negative |
2019 |
41 |
| HTS_TST |
25-29, Female, Negative |
2019 |
479 |
| HTS_TST |
25-29, Female, Negative |
2019 |
45 |
| HTS_TST |
25-29, Male, Negative |
2019 |
2 |
| HTS_TST |
25-29, Male, Negative |
2019 |
28 |
| HTS_TST |
25-29, Male, Negative |
2019 |
493 |
| HTS_TST |
25-29, Male, Negative |
2019 |
58 |
| HTS_TST |
30-34, Female, Negative |
2019 |
24 |
| HTS_TST |
30-34, Female, Negative |
2019 |
84 |
| HTS_TST |
30-34, Female, Negative |
2019 |
540 |
| HTS_TST |
30-34, Female, Negative |
2019 |
110 |
| HTS_TST |
30-34, Male, Negative |
2019 |
35 |
| HTS_TST |
30-34, Male, Negative |
2019 |
114 |
| HTS_TST |
30-34, Male, Negative |
2019 |
521 |
| HTS_TST |
30-34, Male, Negative |
2019 |
1,044 |
| HTS_TST |
35-39, Female, Negative |
2019 |
9 |
| HTS_TST |
35-39, Female, Negative |
2019 |
34 |
| HTS_TST |
35-39, Female, Negative |
2019 |
424 |
| HTS_TST |
35-39, Female, Negative |
2019 |
304 |
| HTS_TST |
35-39, Male, Negative |
2019 |
7 |
| HTS_TST |
35-39, Male, Negative |
2019 |
33 |
| HTS_TST |
35-39, Male, Negative |
2019 |
420 |
| HTS_TST |
35-39, Male, Negative |
2019 |
245 |
| HTS_TST |
40-49, Female, Negative |
2019 |
11 |
| HTS_TST |
40-49, Female, Negative |
2019 |
38 |
| HTS_TST |
40-49, Female, Negative |
2019 |
266 |
| HTS_TST |
40-49, Female, Negative |
2019 |
271 |
| HTS_TST |
40-49, Male, Negative |
2019 |
7 |
| HTS_TST |
40-49, Male, Negative |
2019 |
43 |
| HTS_TST |
40-49, Male, Negative |
2019 |
212 |
| HTS_TST |
40-49, Male, Negative |
2019 |
225 |
| HTS_TST |
By Key Population: FSW, Negative |
2019 |
659 |
| HTS_TST |
By Key Population: MSM, Negative |
2019 |
861 |
| HTS_TST |
By Key Population: TG, Negative |
2019 |
6 |
| HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2019 |
7,204 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 15-19, Female, Negative |
2019 |
63 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 15-19, Male, Negative |
2019 |
46 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 20-24, Female, Negative |
2019 |
81 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 20-24, Male, Negative |
2019 |
63 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 50+, Female, Negative |
2019 |
32 |
| HTS_TST |
Service Delivery Point (Community) Index Mod: 50+, Male, Negative |
2019 |
22 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative |
2019 |
17 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative |
2019 |
11 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative |
2019 |
22 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative |
2019 |
17 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative |
2019 |
5 |
| HTS_TST |
Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative |
2019 |
4 |
| HTS_TST |
Service Delivery Point (Community) Other: 15-19, Female, Negative |
2019 |
117 |
| HTS_TST |
Service Delivery Point (Community) Other: 15-19, Male, Negative |
2019 |
133 |
| HTS_TST |
Service Delivery Point (Community) Other: 20-24, Female, Negative |
2019 |
116 |
| HTS_TST |
Service Delivery Point (Community) Other: 20-24, Male, Negative |
2019 |
184 |
| HTS_TST |
Service Delivery Point (Community) Other: 50+, Female, Negative |
2019 |
194 |
| HTS_TST |
Service Delivery Point (Community) Other: 50+, Male, Negative |
2019 |
178 |
| HTS_TST |
Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative |
2019 |
403 |
| HTS_TST |
Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative |
2019 |
451 |
| HTS_TST |
Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative |
2019 |
481 |
| HTS_TST |
Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative |
2019 |
553 |
| HTS_TST |
Service Delivery Point (Facility) Other PITC: 50+, Female, Negative |
2019 |
139 |
| HTS_TST |
Service Delivery Point (Facility) Other PITC: 50+, Male, Negative |
2019 |
142 |
| HTS_TST_POS |
25-29, Female, Positive |
2019 |
1 |
| HTS_TST_POS |
25-29, Female, Positive |
2019 |
21 |
| HTS_TST_POS |
25-29, Female, Positive |
2019 |
30 |
| HTS_TST_POS |
25-29, Female, Positive |
2019 |
16 |
| HTS_TST_POS |
25-29, Male, Positive |
2019 |
1 |
| HTS_TST_POS |
25-29, Male, Positive |
2019 |
21 |
| HTS_TST_POS |
25-29, Male, Positive |
2019 |
23 |
| HTS_TST_POS |
25-29, Male, Positive |
2019 |
25 |
| HTS_TST_POS |
30-34, Female, Positive |
2019 |
6 |
| HTS_TST_POS |
30-34, Female, Positive |
2019 |
51 |
| HTS_TST_POS |
30-34, Female, Positive |
2019 |
43 |
| HTS_TST_POS |
30-34, Male, Positive |
2019 |
1 |
| HTS_TST_POS |
30-34, Male, Positive |
2019 |
18 |
| HTS_TST_POS |
30-34, Male, Positive |
2019 |
30 |
| HTS_TST_POS |
30-34, Male, Positive |
2019 |
7 |
| HTS_TST_POS |
35-39, Female, Positive |
2019 |
1 |
| HTS_TST_POS |
35-39, Female, Positive |
2019 |
26 |
| HTS_TST_POS |
35-39, Female, Positive |
2019 |
41 |
| HTS_TST_POS |
35-39, Female, Positive |
2019 |
18 |
| HTS_TST_POS |
35-39, Male, Positive |
2019 |
1 |
| HTS_TST_POS |
35-39, Male, Positive |
2019 |
21 |
| HTS_TST_POS |
35-39, Male, Positive |
2019 |
32 |
| HTS_TST_POS |
35-39, Male, Positive |
2019 |
2 |
| HTS_TST_POS |
40-49, Female, Positive |
2019 |
16 |
| HTS_TST_POS |
40-49, Female, Positive |
2019 |
19 |
| HTS_TST_POS |
40-49, Female, Positive |
2019 |
14 |
| HTS_TST_POS |
40-49, Male, Positive |
2019 |
1 |
| HTS_TST_POS |
40-49, Male, Positive |
2019 |
12 |
| HTS_TST_POS |
40-49, Male, Positive |
2019 |
17 |
| HTS_TST_POS |
40-49, Male, Positive |
2019 |
2 |
| HTS_TST_POS |
By Key Population: FSW, Positive |
2019 |
64 |
| HTS_TST_POS |
By Key Population: MSM, Positive |
2019 |
48 |
| HTS_TST_POS |
By Key Population: TG, Positive |
2019 |
1 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 15-19, Female, Positive |
2019 |
16 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 15-19, Male, Positive |
2019 |
5 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 20-24, Female, Positive |
2019 |
11 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 20-24, Male, Positive |
2019 |
14 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 50+, Female, Positive |
2019 |
5 |
| HTS_TST_POS |
Service Delivery Point (Community) Index Mod: 50+, Male, Positive |
2019 |
5 |
| HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive |
2019 |
1 |
| HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive |
2019 |
1 |
| HTS_TST_POS |
Service Delivery Point (Community) Other: 15-19, Female, Positive |
2019 |
2 |
| HTS_TST_POS |
Service Delivery Point (Community) Other: 15-19, Male, Positive |
2019 |
24 |
| HTS_TST_POS |
Service Delivery Point (Community) Other: 20-24, Female, Positive |
2019 |
16 |
| HTS_TST_POS |
Service Delivery Point (Community) Other: 20-24, Male, Positive |
2019 |
14 |
| HTS_TST_POS |
Service Delivery Point (Community) Other: 50+, Female, Positive |
2019 |
15 |
| HTS_TST_POS |
Service Delivery Point (Community) Other: 50+, Male, Positive |
2019 |
5 |
| HTS_TST_POS |
Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive |
2019 |
15 |
| HTS_TST_POS |
Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive |
2019 |
23 |
| HTS_TST_POS |
Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive |
2019 |
22 |
| HTS_TST_POS |
Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive |
2019 |
12 |
| HTS_TST_POS |
Service Delivery Point (Facility) Other PITC: 50+, Female, Positive |
2019 |
24 |
| HTS_TST_POS |
Service Delivery Point (Facility) Other PITC: 50+, Male, Positive |
2019 |
5 |
| KP_PREV |
By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2019 |
10,986 |
| KP_PREV |
By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2019 |
3,915 |
| KP_PREV |
By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2019 |
45 |
| KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2019 |
14,946 |
| PrEP_NEW |
Female 15-19 |
2019 |
145 |
| PrEP_NEW |
Female 20-24 |
2019 |
492 |
| PrEP_NEW |
FSW |
2019 |
240 |
| PrEP_NEW |
Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection |
2019 |
638 |
| TX_CURR |
25-29, Female, Positive |
2019 |
145 |
| TX_CURR |
25-29, Male, Positive |
2019 |
86 |
| TX_CURR |
30-34, Female, Positive |
2019 |
203 |
| TX_CURR |
30-34, Male, Positive |
2019 |
130 |
| TX_CURR |
35-39, Female, Positive |
2019 |
239 |
| TX_CURR |
35-39, Male, Positive |
2019 |
159 |
| TX_CURR |
40-49, Female, Positive |
2019 |
380 |
| TX_CURR |
40-49, Male, Positive |
2019 |
278 |
| TX_CURR |
Age/Sex: 15-19 Female |
2019 |
37 |
| TX_CURR |
Age/Sex: 15-19 Male |
2019 |
28 |
| TX_CURR |
Age/Sex: 20-24 Female |
2019 |
82 |
| TX_CURR |
Age/Sex: 20-24 Male |
2019 |
50 |
| TX_CURR |
Age/Sex: 50+ Female |
2019 |
272 |
| TX_CURR |
Age/Sex: 50+ Male |
2019 |
219 |
| TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2019 |
2,308 |
| TX_CURR |
Sum of age/sex disaggregates |
2019 |
65 |
| TX_NEW |
25-29, Female, Positive |
2019 |
37 |
| TX_NEW |
25-29, Male, Positive |
2019 |
71 |
| TX_NEW |
30-34, Female, Positive |
2019 |
37 |
| TX_NEW |
30-34, Male, Positive |
2019 |
86 |
| TX_NEW |
35-39, Female, Positive |
2019 |
50 |
| TX_NEW |
35-39, Male, Positive |
2019 |
82 |
| TX_NEW |
40-49, Female, Positive |
2019 |
84 |
| TX_NEW |
40-49, Male, Positive |
2019 |
116 |
| TX_NEW |
By Age/Sex: 15-19 Female |
2019 |
6 |
| TX_NEW |
By Age/Sex: 15-19 Male |
2019 |
6 |
| TX_NEW |
By Age/Sex: 20-24 Female |
2019 |
25 |
| TX_NEW |
By Age/Sex: 20-24 Male |
2019 |
42 |
| TX_NEW |
By Age/Sex: 50+ Female |
2019 |
95 |
| TX_NEW |
By Age/Sex: 50+ Male |
2019 |
119 |
| TX_NEW |
FSW |
2019 |
224 |
| TX_NEW |
MSM |
2019 |
107 |
| TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2019 |
856 |
| TX_NEW |
Pregnancy status |
2019 |
25 |
| TX_NEW |
Sum of Age/Sex disaggregates |
2019 |
293 |
| TX_PVLS |
Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months |
2019 |
2,383 |
| TX_PVLS_den |
Denominator: Aggregate Age/Sex by Indication: <15 Female Routine |
2019 |
86 |
| TX_PVLS_den |
Denominator: Aggregate Age/Sex by Indication: <15 Male Routine |
2019 |
84 |
| TX_PVLS_den |
Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine |
2019 |
1,421 |
| TX_PVLS_den |
Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine |
2019 |
792 |
| TX_PVLS_den |
Denominator: Indication: Routine |
2019 |
2,383 |
| TX_RET |
Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2019 |
411 |
| TX_RET |
Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) |
2019 |
203 |
| TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2019 |
614 |
| TX_RET |
Numerator by Status: Pregnant |
2019 |
7 |
| TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2019 |
876 |
| TX_RET_den |
Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2019 |
599 |
| TX_RET_den |
Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) |
2019 |
277 |
| TX_RET_den |
Denominator by Status: Pregnant |
2019 |
12 |
